- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02603237
Metabolic Response to Fat and Glucose
May 2, 2023 updated by: Rima Obeid, Universität des Saarlandes
The study will compare plasma and urine post-prandial metabolomics after fat and glucose oral load according to lifestyle factors.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The metabolic response in plasma and urine, pre- and post-load tests in people with specific dietary lifestyles will be tested.
This project will focus on fat and glucose induced changes of targeted metabolic pathways that have been related to diabetes and obesity risk.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saarland
-
Homburg, Saarland, Germany, 66424
- University of Saarland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy volunteers
- On a stable dietary habits
Exclusion Criteria:
- Pregnancy
- Malabsorption disorders
- Present or former cancer
- Any oral medication that affect glucose or fat absorptions
- Cholesterol lowering drugs (i.e. Statins)
- other drugs: fibrates, MTX, or vitamin supplements
- Diabetes (type 1 and type 2)
- Alcoholism
- Weight losing diet during the last 4 months
- Liver diseases
- Renal dysfunction
- Gastric resection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Glucose tolerance test
All participants will receive an oral standardized glucose tolerance test
|
Standardized oral glucose tolerance test (75 g oral glucose) and blood collection before and 2hrs after the glucose load
|
|
Other: Fat tolerance test
The same participants will receive an oral standardized fat load test
|
Oral fat tolerance will be provided to fasting participants and blood samples will be collected before and 4 hrs after the fat load.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma levels of branched chain amino acid
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma Trimethylamin N-oxide
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma glucose level
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma glucose
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma level of acetyl-CoA
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma malonyl-CoA
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma phosphatidylcholine
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma insulin
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma leptin
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma Lactate
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
|
Plasma pyruvate
Time Frame: Changes between baseline and 2 hours
|
Changes between baseline and 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Rima Obeid, Universität Des Saarlandes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
June 1, 2020
Study Registration Dates
First Submitted
November 6, 2015
First Submitted That Met QC Criteria
November 10, 2015
First Posted (Estimate)
November 11, 2015
Study Record Updates
Last Update Posted (Estimate)
May 4, 2023
Last Update Submitted That Met QC Criteria
May 2, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Postprandial metabolomics
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
will be decided at a later stage
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.